Morning Trend | Incyte shows bottom fluctuations, is the short-term opportunity a real breakthrough or a false signal?

Incyte (INCY.US) experienced a long period of sluggishness, but yesterday the market showed signs of bottoming out, with funds tentatively flowing back in and a significant increase in bottom trading volume. This has raised market attention on "whether it coincides with the rotation of the pharmaceutical sector, leading to a short-term rebound." During the trading session, institutions frequently switched between high and low positions, with major players both accumulating shares and taking profits, leading to increased market divergence. If the funds can break through the previous dense resistance levels with increased volume, a rapid surge may be on the horizon; conversely, if there is continued profit-taking at high levels, caution is needed for potential pullback pressure. It is recommended to pay attention to intraday trading volume and the net buying flow of major players, to grasp the turning point of pharmaceutical sentiment, and to control pullbacks in a timely manner when volume is insufficient. Focus on short-term trading, and set appropriate profit-taking and stop-loss levels